Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell–mediated gene therapy

ADAMTS13, a metalloprotease primarily synthesized in liver and endothelial cells, cleaves von Willebrand factor (VWF) at the central A2 domain, thereby reducing the sizes of circulating VWF multimers. Genetic or acquired deficiency of plasma ADAMTS13 activity leads to a potentially fatal syndrome, t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Laje, Pablo, Shang, Dezhi, Cao, Wenjing, Niiya, Masami, Endo, Masayuki, Radu, Antoneta, DeRogatis, Nicole, Scheiflinger, Friedrich, Zoltick, Philip W., Flake, Alan W., Zheng, X. Long
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2009
Assuntos:
Gene Therapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2652365/
https://ncbi.nlm.nih.gov/pubmed/19141866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-08-173021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados